Millennium Management Amends Maravai LifeSciences Stake

TL;DR

**Millennium Management updated its stake in Maravai LifeSciences, signaling a portfolio adjustment.**

AI Summary

Millennium Management LLC, a Delaware-based investment firm, filed an amended SC 13G/A on January 5, 2024, indicating a change in their ownership of Maravai LifeSciences Holdings, Inc. Class A Common Stock as of December 31, 2023. This filing updates their previous disclosure, signaling a potential adjustment in their investment strategy for Maravai. Investors should note this as it reflects a significant institutional investor's updated position, which could influence market sentiment or future trading activity for Maravai stock.

Why It Matters

This filing shows an updated position from a major institutional investor, Millennium Management LLC, which can signal their current view on Maravai LifeSciences Holdings, Inc. and potentially influence other investors.

Risk Assessment

Risk Level: low — This filing is an amendment to a passive ownership disclosure and does not indicate any immediate, significant risk to the company or its shareholders.

Analyst Insight

Investors should monitor future 13F filings to see if Millennium Management LLC further increases or decreases its position in Maravai LifeSciences, as this could signal a shift in institutional sentiment.

Key Numbers

• 56600D107 — CUSIP Number (Identifies Maravai LifeSciences Holdings, Inc. Class A Common Stock)
• 0001273087 — Central Index Key (CIK) (Identifies Millennium Management LLC)
• 0001823239 — Central Index Key (CIK) (Identifies Maravai LifeSciences Holdings, Inc.)
• 20240105 — Filing Date (Date the SC 13G/A was filed with the SEC)
• 20231231 — Date of Event (Date as of which the ownership change occurred)

Key Players & Entities

• Millennium Management LLC (company) — the reporting person filing the SC 13G/A
• Maravai LifeSciences Holdings, Inc. (company) — the subject company whose stock is being reported
• Israel A. Englander (person) — a group member associated with Millennium Management LLC
• Millennium Group Management LLC (company) — a group member associated with Millennium Management LLC
• $0.01 (dollar_amount) — par value per share of Class A Common Stock

Forward-Looking Statements

• Millennium Management LLC will continue to adjust its stake in Maravai LifeSciences Holdings, Inc. based on market conditions. (Millennium Management LLC) — medium confidence, target: Q1 2024

FAQ

Key Financial Figures

• $0.01 — suer) CLASS A COMMON STOCK, PAR VALUE $0.01 PER SHARE (Title of Class of Securiti

Filing Documents

• MRVI_SC13GA1.htm (SC 13G/A) — 78KB
• 0001273087-24-000003.txt ( ) — 80KB

If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b), check whether the person filing is

Item 3. If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b), check whether the person filing is a: (a) o Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o); (b) o Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c); (c) o Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c); (d) o Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8); (e) o An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E); (f) o An employee benefit plan or endowment fund in accordance with 240.13d-1(b)(1)(ii)(F); CUSIP No. 56600D107 SCHEDULE 13G Page 6 of 10 (g) o A parent holding company or control person in accordance with 240.13d-1(b)(1)(ii)(G); (h) o A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) o A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) o Group, in accordance with 240.13d-1(b)(1)(ii)(J).

Ownership

Item 4. Ownership Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. (a) Amount Beneficially Owned: See response to Item 9 on each cover page. (b) Percent of Class: See response to Item 11 on each cover page. (c) Number of shares as to which such person has: (i) Sole power to vote or to direct the vote See response to Item 5 on each cover page. CUSIP No. 56600D107 SCHEDULE 13G Page 7 of 10 (ii) Shared power to vote or to direct the vote See response to Item 6 on each cover page. (iii) Sole power to dispose or to direct the disposition of See response to Item 7 on each cover page. (iv) Shared power to dispose or to direct the disposition of See response to Item 8 on each cover page. The securities disclosed herein as potentially beneficially owned by Millennium Management LLC, Millennium Group Management LLC and Mr. Englander are held by entities subject to voting control and investment discretion by Millennium Management LLC and/or other investment managers that may be controlled by Millennium Group Management LLC (the managing member of Millennium Management LLC) and Mr. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). The foregoing should not be construed in and of itself as an admission by Millennium Management LLC, Millennium Group Management LLC or Mr. Englander as to beneficial ownership of the securities held by such entities.

Ownership of Five Percent or Less of a Class

Item 5. Ownership of Five Percent or Less of a Class If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following .

Ownership of More than Five Percent on Behalf of Another Person

Item 6. Ownership of More than Five Percent on Behalf of Another Person. Not applicable.

Identification and Classification of the Subsidiary Which Acquired

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. Not applicable.

Identification and Classification of Members of the Group

Item 8. Identification and Classification of Members of the Group See Exhibit I.

Notice of Dissolution of Group

Item 9. Notice of Dissolution of Group Not applicable.

Certification

Item 10. Certification By signing below each of the undersigned certifies that, to the best of its knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. CUSIP No. 56600D107 SCHEDULE 13G Page 8 of 10 Exhibits: Exhibit I: Joint Filing Agreement, dated as of January 4, 2024, by and among Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander. CUSIP No. 56600D107 SCHEDULE 13G Page 9 of 10 SIGNATURE After reasonable inquiry and to the best of its knowledge and belief, each of the undersigned certifies that the information with respect to it set forth in this statement is true, complete, and correct. Dated: January 4, 2024 MILLENNIUM MANAGEMENT LLC By: /s/Gil Raviv Name: Gil Raviv Title: Global General Counsel MILLENNIUM GROUP MANAGEMENT LLC By: /s/Gil Raviv Name: Gil Raviv Title: Global General Counsel /s/ Israel A. Englander Israel A. Englander CUSIP No. 56600D107 SCHEDULE 13G Page 10 of 10 EXHIBIT I JOINT FILING AGREEMENT This will confirm the agreement by and among the undersigned that the Schedule 13G filed with the Securities and Exchange Commission on or about the date hereof with respect to the beneficial ownership by the undersigned of the Class A Common Stock, par value $0.01 per share, of Maravai LifeSciences Holdings, Inc. will be filed on behalf of each of the persons and entities named below in accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. Dated: January 4, 2024 MILLENNIUM MANAGEMENT

View Full Filing

View this SC 13G/A filing on SEC EDGAR